BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

707 related articles for article (PubMed ID: 26288386)

  • 1. Biodegradation and Toxicity of Protease/Redox/pH Stimuli-Responsive PEGlated PMAA Nanohydrogels for Targeting Drug delivery.
    Jin S; Wan J; Meng L; Huang X; Guo J; Liu L; Wang C
    ACS Appl Mater Interfaces; 2015 Sep; 7(35):19843-52. PubMed ID: 26288386
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Redox/pH dual stimuli-responsive biodegradable nanohydrogels with varying responses to dithiothreitol and glutathione for controlled drug release.
    Pan YJ; Chen YY; Wang DR; Wei C; Guo J; Lu DR; Chu CC; Wang CC
    Biomaterials; 2012 Sep; 33(27):6570-9. PubMed ID: 22704845
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Zinc finger-inspired nanohydrogels with glutathione/pH triggered degradation based on coordination substitution for highly efficient delivery of anti-cancer drugs.
    Zhang Z; Wan J; Sun L; Li Y; Guo J; Wang C
    J Control Release; 2016 Mar; 225():96-108. PubMed ID: 26812007
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preparation of biodegradable PEGylated pH/reduction dual-stimuli responsive nanohydrogels for controlled release of an anti-cancer drug.
    Zhou T; Zhao X; Liu L; Liu P
    Nanoscale; 2015 Jul; 7(28):12051-60. PubMed ID: 26118938
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Charge reversible and biodegradable nanocarriers showing dual pH-/reduction-sensitive disintegration for rapid site-specific drug delivery.
    Miao Y; Qiu Y; Yang W; Guo Y; Hou H; Liu Z; Zhao X
    Colloids Surf B Biointerfaces; 2018 Sep; 169():313-320. PubMed ID: 29800906
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reduction-responsive disassemblable core-cross-linked micelles based on poly(ethylene glycol)-b-poly(N-2-hydroxypropyl methacrylamide)-lipoic acid conjugates for triggered intracellular anticancer drug release.
    Wei R; Cheng L; Zheng M; Cheng R; Meng F; Deng C; Zhong Z
    Biomacromolecules; 2012 Aug; 13(8):2429-38. PubMed ID: 22746534
    [TBL] [Abstract][Full Text] [Related]  

  • 7. pH/Reduction Dual-Responsive Oxidized Alginate-Doxorubicin (mPEG-OAL-DOX/Cys) Prodrug Nanohydrogels: Effect of Complexation with Cyclodextrins.
    Zhou T; Li J; Jia X; Zhao X; Liu P
    Langmuir; 2018 Jan; 34(1):416-424. PubMed ID: 29237263
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Smart pH- and reduction-dual-responsive folate-PEG-coated polymeric lipid vesicles for tumor-triggered targeted drug delivery.
    Wang S; Wang H; Liu Z; Wang L; Wang X; Su L; Chang J
    Nanoscale; 2014 Jul; 6(13):7635-42. PubMed ID: 24898341
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Superparamagnetic Reduction/pH/Temperature Multistimuli-Responsive Nanoparticles for Targeted and Controlled Antitumor Drug Delivery.
    Zeng J; Du P; Liu L; Li J; Tian K; Jia X; Zhao X; Liu P
    Mol Pharm; 2015 Dec; 12(12):4188-99. PubMed ID: 26554495
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Self-Assembly Assisted Fabrication of Dextran-Based Nanohydrogels with Reduction-Cleavable Junctions for Applications as Efficient Drug Delivery Systems.
    Wang H; Dai T; Zhou S; Huang X; Li S; Sun K; Zhou G; Dou H
    Sci Rep; 2017 Jan; 7():40011. PubMed ID: 28071743
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Folic acid-conjugated pH/temperature/redox multi-stimuli responsive polymer microspheres for delivery of anti-cancer drug.
    Li R; Feng F; Wang Y; Yang X; Yang X; Yang VC
    J Colloid Interface Sci; 2014 Sep; 429():34-44. PubMed ID: 24935187
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Functionalized graphene oxide nanoparticles for cancer cell-specific delivery of antitumor drug.
    Zhao X; Yang L; Li X; Jia X; Liu L; Zeng J; Guo J; Liu P
    Bioconjug Chem; 2015 Jan; 26(1):128-36. PubMed ID: 25525819
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Versatile functionalization of surface-tailorable polymer nanohydrogels for drug delivery systems.
    Yang WJ; Liang L; Wang X; Cao Y; Xu W; Chang D; Gao Y; Wang L
    Biomater Sci; 2018 Dec; 7(1):247-261. PubMed ID: 30465554
    [TBL] [Abstract][Full Text] [Related]  

  • 14. pH and glutathion-responsive hydrogel for localized delivery of paclitaxel.
    Pérez E; Fernández A; Olmo R; Teijón JM; Blanco MD
    Colloids Surf B Biointerfaces; 2014 Apr; 116():247-56. PubMed ID: 24491841
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Poly(vinylcaprolactam)-based biodegradable multiresponsive microgels for drug delivery.
    Wang Y; Nie J; Chang B; Sun Y; Yang W
    Biomacromolecules; 2013 Sep; 14(9):3034-46. PubMed ID: 23909593
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Improved antitumor effect of paclitaxel administered in vivo as pH and glutathione-sensitive nanohydrogels.
    Pérez E; Martínez A; Teijón C; Olmo R; Teijón JM; Blanco MD
    Int J Pharm; 2015 Aug; 492(1-2):10-9. PubMed ID: 26160666
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel free-paclitaxel-loaded redox-responsive nanoparticles based on a disulfide-linked poly(ethylene glycol)-drug conjugate for intracellular drug delivery: synthesis, characterization, and antitumor activity in vitro and in vivo.
    Chuan X; Song Q; Lin J; Chen X; Zhang H; Dai W; He B; Wang X; Zhang Q
    Mol Pharm; 2014 Oct; 11(10):3656-70. PubMed ID: 25208098
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assembling of stimuli-responsive tumor targeting polypyrrole nanotubes drug carrier system for controlled release.
    Chen J; Li X; Li J; Li J; Huang L; Ren T; Yang X; Zhong S
    Mater Sci Eng C Mater Biol Appl; 2018 Aug; 89():316-327. PubMed ID: 29752103
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A pH and redox dual stimuli-responsive poly(amino acid) derivative for controlled drug release.
    Gong C; Shan M; Li B; Wu G
    Colloids Surf B Biointerfaces; 2016 Oct; 146():396-405. PubMed ID: 27388968
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intelligent anticancer drug delivery performances of two poly(N-isopropylacrylamide)-based magnetite nanohydrogels.
    Poorgholy N; Massoumi B; Ghorbani M; Jaymand M; Hamishehkar H
    Drug Dev Ind Pharm; 2018 Aug; 44(8):1254-1261. PubMed ID: 29452515
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 36.